Commentary

Commenting on a recent article by Lester et al, the authors discuss the psychological impacts of diagnosis, genetic testing, and disease progression on patients with amyotrophic lateral sclerosis (ALS).

The evidence about long-term benzodiazepine use presents a confounding paradox. This commentary proposes a set of prescribing guidelines for clinicians.

Randall T. Espinoza, MD, and Aaron Kaufman, MD, discuss a study by Trevisan et al and reflect on lessons learned during the pandemic about detecting and managing delirium.

Rachel Vanderkruik, PhD, MSc, discusses Huh and colleagues’ study of online nurse-delivered group CBT for postpartum depression, highlighting 4 key aspects that make the intervention particularly exciting.

Although the administration intervals of long-acting injectable antipsychotics are a starting point for scheduling follow-ups, frequency of prescriber contact should be based on individual risk factors and real-world constraints.

The authors argue that insurance companies’ prior authorization process overly restricts access to rTMS, which has proven effectiveness for TRD.